Porcine Circovirus Type 2 is a significant infectious agent in global swine production, caused by Porcine Circovirus Type 2 (PCV-2), belonging to the family Circoviridae, genus Circovirus. This virus is associated with a group of diseases known as Porcine Circovirus Associated Diseases (PCVAD), which are responsible for significant economic losses due to reduced zootechnical performance, increased mortality, and rising sanitary costs.
PCV-2 has a widespread geographic distribution and a high capacity for persistence within herds. Transmission occurs both horizontally—through direct contact between animals, secretions, excretions, and fomites—and vertically, from the sow to the piglets. Infection is frequently favored by stress factors, co-infections, and management failures.
Clinical manifestations associated with PCV-2 are varied and can include progressive weight loss, growth retardation, lymphadenopathy, and respiratory, enteric, and reproductive disorders. Many animals may present with subclinical infection, acting as viral reservoirs and contributing to the maintenance of the infection within herds.
Prevention and control of Porcine Circovirus Type 2 are based on integrated sanitary management programs. Vaccination is one of the primary control tools, demonstrating high efficacy in reducing viral load, clinical severity, and production losses. These measures must be combined with biosecurity, the control of co-infections, and good management practices.
Laboratory diagnosis is essential for monitoring PCV-2 infection. Molecular methods, such as PCR, allow for the detection and quantification of the virus, while histopathological and serological examinations assist in diagnostic confirmation and in evaluating the impact of the infection on the herd.
Continuous epidemiological surveillance, combined with the rational use of vaccines and proper management, is fundamental for the sustainable control of PCV-2. These strategies contribute to the improvement of herd health, increased productivity, and the strengthening of the sustainability of the swine production chain.
*]:pointer-events-auto scroll-mt-[calc(var(–header-height)+min(200px,max(70px,20svh)))]” dir=”auto” tabindex=”-1″ data-turn-id=”request-WEB:fe9b6517-792e-400f-9654-1c43d01eef55-16″ data-testid=”conversation-turn-34″ data-scroll-anchor=”true” data-turn=”assistant”>
In this context, the Bioperfectus Porcine Circovirus Type 2 (PCV-2) rapid test represents a practical screening tool to support sanitary surveillance in swine herds. The application of the rapid test enables the agile identification of suspected animals directly in the field, including subclinical cases or situations involving a decline in zootechnical performance, aiding in immediate decision-making such as lot segregation, adjustments in sanitary management, and the referral of samples for laboratory confirmation. In this way, the rapid test complements conventional diagnostic methods, contributing to the early detection of PCV-2 circulation, the reduction of viral dissemination, and the strengthening of control strategies for porcine circovirus-associated diseases.
